Doxorubicin Hydrochloride Liposome

Baxter Healthcare Company🇺🇸 United States

FDA Page

Effective Date: May 31, 2022
Approval ID: cf25a018-e795-49e4-8533-a581f8366dd9
Products: 2 registered
Version: 7

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION safely and effectively. See full prescribing information for Doxorubicin hydrochloride liposome injection. Doxorubicin Hydrochloride Liposome Injection, for intravenous useInitial U.S. Approval: 1995

Quick Stats

Total Products2

Labelers3

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.